MaxQ AI is at the forefront of Medical Diagnostic AI. Our mission is to meaningfully reduce misdiagnosis and healthcare costs by making artificial intelligence (AI) intrinsic to the diagnostic process for time sensitive and life-threatening conditions. We are transforming healthcare by empowering physicians to provide ‘smarter care’ through intelligent imaging with AI actionable insights. Our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing stroke, brain trauma, and other serious conditions.
The complete Accipio platform will support the Radiologist, Emergency Room, and Neurorad teams with a fully-automated solution. Accipio uses MaxQ AI’s INSIGHT™ method, providing prioritization (Ix1), annotation (Ax2), and expert-level diagnostic rule out (Dx2). The complete ICH solution for head trauma and stroke care promises to:
"We serve multiple hospitals where we may have several CT head cases with other stat exams to read – with no way of knowing what is the most acute without adding more radiologists – this risk exposure is amplified when a priority stroke case hits the ED. Having an intelligent agent prioritize these cases would increase safety, improve patient care and inform staffing decisions."
The Accipio platform will support the Radiologist, Emergency Room and Neuro-rad teams with a fully-automated solution. Accipio uses MaxQ Al's INSIGHT™ method, providing identification & prioritization (lx1), annotation (Ax2) and expert-level diagnostic rule out (Dx2). The complete ICH solution for head trauma and stroke care promises to:
US Regulatory Status: Accipio Ix is FDA Cleared, CE Approved. Accipio Ax and Dx are not FDA Cleared, not CE Approved and for investigational use only.